These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38161980)

  • 1. The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes.
    Cao J; He X; Li X; Sun Y; Zhang W; Li Y; Zhu X
    Front Endocrinol (Lausanne); 2023; 14():1253394. PubMed ID: 38161980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C; Duan D; Liu S
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.
    Jin M; Kim M; Jeon MJ; Kim EY; Shin DY; Kim BH; Kim WB; Shong YK; Lim DJ; Kim WG
    Endocrine; 2023 Aug; 81(2):298-305. PubMed ID: 36928602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study.
    Huang Y; Liu Y; Mo G; Zhou T; Hou Q; Shi C; Jiang Q; Lv Y
    Cancer Control; 2022; 29():10732748221115236. PubMed ID: 35833862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib.
    Kim CA; Kim M; Jin M; Kim HK; Jeon MJ; Lim DJ; Kim BH; Kang HC; Kim WB; Shin DY; Kim WG
    Endocrinol Metab (Seoul); 2024 Apr; 39(2):334-343. PubMed ID: 38572536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.
    Kim K; Pak K; Kim IJ; Kim M; Kim BH; Lee BJ; Kim SJ
    Endocrine; 2020 Nov; 70(2):364-371. PubMed ID: 32372305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma.
    Li C; Li J; Li S; Zhao Y; Liu G; Du R; Dionigi G; Liang N; Sun H
    Front Endocrinol (Lausanne); 2022; 13():984157. PubMed ID: 36060974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma.
    Gu Y; Yu M; Deng J; Lai Y
    Int J Gen Med; 2024; 17():2887-2897. PubMed ID: 38974140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
    Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
    Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
    J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma.
    Li C; Zhang H; Li S; Zhang D; Li J; Dionigi G; Liang N; Sun H
    Front Endocrinol (Lausanne); 2022; 13():861869. PubMed ID: 35350101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Correlation of Clinicopathological Findings and Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma.
    Ceylan Y; Kumanlıoğlu K; Oral A; Ertan Y; Özcan Z
    Mol Imaging Radionucl Ther; 2019 Mar; 28(1):15-20. PubMed ID: 30942057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
    Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
    J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of factors influencing the clinical outcome after surgery and
    Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
    Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y; Zhu G; Ouyang W; Pan L; Feng H; Wu J; Chen P; Wang J; Xian J
    Endocr Pract; 2019 Sep; 25(9):887-898. PubMed ID: 31170371
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD.
    Luo Z; Zhang W; Chen L; Xu N
    Int J Gen Med; 2021; 14():2839-2848. PubMed ID: 34211292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.